📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine. (2022)

First Author: Kilonzi M

Attributed to: Systems Science Research in Public Health (SysSci) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/f1000research.111300.1

PubMed Identifier: 37638133

Publication URI: http://europepmc.org/abstract/MED/37638133

Type: Journal Article/Review

Volume: 11

Parent Publication: F1000Research

ISSN: 2046-1402